Streetbeat News

Equity Actions

EXPE

Expedia Group has announced that Ariane Gorin will succeed Peter Kern as CEO. This leadership change is part of the company's ongoing strategy to strengthen its position in the travel industry. The transition is expected to bring fresh perspectives to Expedia's operations and potentially drive innovation and growth within the company.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 9:03 pm

EXPE

Expedia Group has announced the appointment of Ariane Gorin as its new CEO, effective May 13, 2024. This strategic leadership change is expected to guide the company through its next phase of growth and innovation.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 9:02 pm

ALL

11 financial analysts have recently updated their ratings and price targets for Allstate (NYSE:ALL), showing a mix of bullish to bearish sentiments. The average 12-month price target has been raised to $166.73, indicating a 16.86% increase from the previous target. Analysts from firms like JP Morgan, Raymond James, and Goldman Sachs have raised their price targets, reflecting optimism about Allstate's future performance despite challenges in revenue growth, net margin, and debt management.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 9:00 pm

DWAC

Digital World Acquisition Corp (DWAC) is reportedly close to finalizing a deal involving a $50 million convertible note, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 8:21 pm

ENR

Energizer Holdings (NYSE:ENR) has received mixed analyst ratings over the past three months, with a shift towards a more cautious stance in the last 30 days. The average 12-month price target has been adjusted to $35.57, marking a 2.81% decrease from the previous target of $36.60. Analyst actions include both upgrades and downgrades, reflecting varied perspectives on the company's performance and market conditions. Energizer, known for its battery and lighting products, faces challenges such as a decline in revenue growth, below-average net margin, and a high debt-to-equity ratio, impacting its financial health.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 8:01 pm

CRTO

In the last three months, Criteo (NASDAQ:CRTO) received mixed analyst ratings, ranging from bullish to bearish. The average 12-month price target for CRTO has been raised to $33.25, marking a 21.66% increase from the previous target. Analysts from BMO Capital, Susquehanna, and Wells Fargo have adjusted their ratings and price targets, reflecting a positive outlook on Criteo's market performance despite its challenges in revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 8:01 pm

GLPI

Analyst ratings for Gaming and Leisure Props (NASDAQ:GLPI) show mixed sentiments with a recent shift towards a more bullish outlook. The average 12-month price target has been raised to $50.0, indicating a 3.09% increase from the previous target. The company's financial performance is strong, with significant revenue growth, high net margin, and efficient use of equity and assets. GLPI's prudent debt management and substantial market capitalization further underscore its robust market position.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 8:01 pm

LMT

Rep. Kathy Manning disclosed the purchase of Lockheed Martin Corp (NYSE:LMT) shares before making a statement on holding Iran accountable after a drone attack in Jordan killed three U.S. soldiers. The transactions, potentially made by her spouse, could indicate a conflict of interest as defense stocks like LMT may benefit from increased military action. Manning, a member of the Committee on Foreign Affairs, has made over 700 trades since taking office. Lockheed Martin's stock could rise if the U.S. retaliates against Iran, as indicated by statements from President Biden and Defense Secretary Lloyd Austin.

Portfolio Pulse from Chris Katje

February 08, 2024 | 7:44 pm

MRNS

Jennison Associates LLC has reported a 5.4% stake in Marinus Pharmaceuticals as of December 31, 2023, according to a 13G filing.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 7:00 pm

QLYS

In the past three months, Qualys (NASDAQ:QLYS) received mixed analyst ratings, with a recent shift towards a more cautious outlook. The average 12-month price target was adjusted to $188.75 from $195.67, reflecting a 3.54% decline. Analysts from Stephens & Co., RBC Capital, Wedbush, and Truist Securities have updated their ratings and price targets, indicating varied expectations for the company's performance. Qualys, a provider of cloud security and compliance solutions, has shown impressive revenue growth and profitability metrics, outperforming industry averages in net margin, ROE, and ROA, despite lagging behind in revenue growth compared to its peers.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 7:00 pm